External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Paediatric Oncology

What's new

Sign up or login to unlock the full suite of MEDICALLY features

Jun 12 / Roche
iPODD clinical trial booklet
Booklet providing an overview of the ongoing work of the Roche iPODD (Innovative Pediatric Oncology Drug Development) team, plus a summary of any ongoing pediatric oncology clinical trials.

Sign up or login to unlock the full suite of MEDICALLY features

Independent content
Jun 16 / Springer Healthcare
In-depth report: Paediatric Oncology
This in-depth report covers sessions on the treatment of paediatric cancers at 2021 ASCO Annual Meeting.

Sign up or login to unlock the full suite of MEDICALLY features

Mar 16 / Roche and Genentech
Characterization of the pharmacokinetics of ▼entrectinib and its active M5 metabolite in pediatric patients with solid tumors
This poster reports the pharmacokinetics (PK) of ▼entrectinib and its active metabolite, M5 in paediatric patients with solid tumours. The findings of this study were used to support the dose recommendations for entrectinib in paediatric patients.

Sign up or login to unlock the full suite of MEDICALLY features

Mar 9 / Roche and Genentech
Combined use of population and physiologically-based PK to support pediatric dose recommendation of ▼entrectinib
This poster presents the results of two approaches, (1) population PK modelling and (2) physiologically-based PK modelling, used to describe the PK of ▼entrectinib and its active metabolite, M5. Findings of the study were used to support the dose recommendations for entrectinib in paediatric patients.

Sign up or login to unlock the full suite of MEDICALLY features

Jun 12 / Roche
iPODD clinical trial booklet
Booklet providing an overview of the ongoing work of the Roche iPODD (Innovative Pediatric Oncology Drug Development) team, plus a summary of any ongoing pediatric oncology clinical trials.

Ask a question or share feedback